Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2015 1
2016 3
2017 1
2018 6
2019 3
2020 3
2022 1
2023 1
2024 3
2025 2
2026 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

22 results

Results by year

Filters applied: . Clear all
Page 1
Abatacept in individuals at high risk of rheumatoid arthritis (APIPPRA): a randomised, double-blind, multicentre, parallel, placebo-controlled, phase 2b clinical trial.
Cope AP, Jasenecova M, Vasconcelos JC, Filer A, Raza K, Qureshi S, D'Agostino MA, McInnes IB, Isaacs JD, Pratt AG, Fisher BA, Buckley CD, Emery P, Ho P, Buch MH, Ciurtin C, van Schaardenburg D, Huizinga T, Toes R, Georgiou E, Kelly J, Murphy C, Prevost AT; APIPPRA study investigators. Cope AP, et al. Lancet. 2024 Mar 2;403(10429):838-849. doi: 10.1016/S0140-6736(23)02649-1. Epub 2024 Feb 13. Lancet. 2024. PMID: 38364839 Free article. Clinical Trial.
Treatment of polymyalgia rheumatica: British Society for Rheumatology guideline scope.
Toyoda T, Armitstead Z, Bhide S, Engamba S, Henderson E, Jones C, MacKeith P, Maddock J, Reynolds G, Scrafton N, Subesinghe M, Subesinghe S, Twohig H, Mackie SL, Yates M. Toyoda T, et al. Among authors: subesinghe s. Rheumatol Adv Pract. 2024 Feb 14;8(1):rkae002. doi: 10.1093/rap/rkae002. eCollection 2024. Rheumatol Adv Pract. 2024. PMID: 38371294 Free PMC article. Review.
Long-term outcomes of abatacept in individuals at risk of developing rheumatoid arthritis (ALTO): a randomised, double-blind, placebo-controlled trial.
Cope AP, Jasenecova M, Vasconcelos JC, Qureshi S, van Schie KA, Filer A, Raza K, D'Agostino MA, McInnes IB, Siebert S, Isaacs JD, Pratt AG, Fisher BA, Buckley CD, Emery P, Mankia K, Ho P, Buch MH, Ciurtin C, van Schaardenburg D, Huizinga TWJ, Toes REM, Georgiou E, Kelly J, Murphy C, Prevost AT; ALTO Study Investigators. Cope AP, et al. Lancet Rheumatol. 2026 Mar;8(3):e171-e180. doi: 10.1016/S2665-9913(25)00371-6. Epub 2026 Jan 20. Lancet Rheumatol. 2026. PMID: 41576971 Free article.
22 results